Canaccord Genuity Maintains a 'Buy' on Summer Infant (SUMR); 2012 Coming Into Focus, and Growth Should Continue

Canaccord Genuity maintains a 'Buy' on Summer Infant (NASDAQ: SUMR) price target of $10.00.

Canaccord analyst, Scott Van Winkle, said, "Summer Infant is a growing brand in an attractive industry with product line expansion, distribution increases and acquisitions fueling growth...Increasing 2011E revenue to $247.1M from $243.7M, while our EPS estimate goes to $0.54 from $0.55. 2012E revenue/EPS goes to $282.5M/$0.74 from $278.3M/$0.71 to reflect stronger sales trends and a more favorable tax rate."

For an analyst ratings summary and ratings history on Summer Infant click here. For more ratings news on Summer Infant click here.

Shares of Summer Infant closed at $7.08 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Deutsche Bank Downgrades Oxford Biomedica (OXB:LN) (OXBDF) to Hold
• UBS Downgrades Scor SE (SCR:FP) (SCRYY) to Sell
• JPMorgan Double Upgrades Hemnet Group AB (HEM:SS) to Overweight